Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03659487
Other study ID # EPN 225/01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2001
Est. completion date October 2018

Study information

Verified date October 2018
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

460 patients who are scheduled for surgical treatment of gastroesophageal reflux disease (GERD) participate in the study following the usual preoperative Clinical routines (Medical history, endoscopy with biopsies, esophageal manometry with 24 hour pH (acidity) registration ). Patients are randomized to fundoplication according to Nissen or modified Toupet. Postoperatively, patients are monitored after 6 weeks 12, 36, 24 and 60 months.


Description:

Patients aged 18-75 years planned for elective surgical treatment of GERD participate in the study. Patients with recurrent reflux disease following prior surgery, ASA (American Society of Anesthesiologists (ASA) Physical Status") class> 3, paraesophageal herniating and / or major herniation without reflux and those with other contraindications against laparoscopic surgery are excluded. In addition, patient completes a QOL protocol. Patients in the study are randomized to laparoscopic fundoplication performed either with a 360 degrees (Nissen) alternatively 270 degree (modified Toupét). Both of these techniques are well established clinical routines. General intubation anesthesia is standardized to all study patients. Discharge from the hospital is typically on the first postoperative day. At a visit, after 6-8 weeks for clinical control, is a QOL protocol is completed as well. After 12 and 36 months, patients undergo upper endoscopy and manometry with 24 hour pH-registration and QOL protocol completion. The latter also occurs after 24 months and 60 months.


Recruitment information / eligibility

Status Completed
Enrollment 460
Est. completion date October 2018
Est. primary completion date April 2011
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- surgery treatment for GERD

- laparoscopic surgery

Exclusion Criteria:

- previous surgery for GERD

- ASA classification >3

- paraesophageal hernias or large hiatal

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Nissen
Laparoscopic total (Nissen) fundoplication
Toupét
Laparoscopic posterior 270 degrees partial fundoplication

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Karolinska Institutet

Outcome

Type Measure Description Time frame Safety issue
Primary Esophageal acid exposure 24-hour pH measurement Change from baseline at 6 weeks, 12 and 36 month
Secondary Recurrens rates Medical journal or patients description Change from baseline at 6 weeks, 12, 36 and 60 month
Secondary Dysphagia scoring Dysphagia for liquids and solids were recorded within a four-graded scale stating the frequency of dysphagia episodes with an arbitrary (empirical) cut off for clinical significance. The same dysphagia scoring was also used in a previous rct, from the same institution, comparing different types of antireflux procedures in open surgery. Change from baseline at 6 weeks, 12, 36 and 60 month
See also
  Status Clinical Trial Phase
Recruiting NCT05326113 - The Effect of Physiotherapy on Post POEM Reflux N/A
Enrolling by invitation NCT05023174 - Platelet Rich Plasma in Hiatal Hernia Repair N/A
Recruiting NCT05750186 - The Effect of Abdominal Massage Applied After Surgery N/A
Recruiting NCT05303298 - Evaluating Acid Reflux After Oesophageal Stenting Using Anti-reflux Stents N/A
Completed NCT05634187 - One-stop-shop Endoscopy in Reflux-patients: Evaluation of ENT and GI Features
Terminated NCT02749071 - An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux N/A
Completed NCT04651829 - Suspicion of Non IgE-mediated Cow's Milk Protein Allergy: Prevalence and Evolution
Completed NCT00551473 - Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg. Phase 1
Completed NCT00405119 - A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine. Phase 2
Completed NCT03959020 - Applying Long-term Follow-up to Improve Patient Selection in Laparoscopic Anti-reflux Surgery
Not yet recruiting NCT05425771 - ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease N/A
Recruiting NCT04695171 - LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm
Completed NCT04344964 - Endoscopy-related Phone Consultation During the COVID-19 Outbreak